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Objectives. Ninety-one fetuses with dilated or hypertrophic cardiomyopathy (DCM, HCM) and myocarditis were studied. Results.
G r o u p1“ D C M ”included 19 fetuses: 13 with hydrops (FH) and 5 with associated extracardiac anomalies (ECAs) (15.8%). Group
2 “Myocarditis” included twelve fetuses, having 11 with FH. Group 3 “HCM” included sixty fetuses: 26 had associated ECAs, 17
had maternal diabetes, and 17 were “idiopathic”; however, in one case, a metabolic disorder was found postnatally, and 4 had
familiarity for HCM. Outcomes. Ten cases opted for termination of pregnancy. Two cases with DCM and 1 with HCM were lost at
follow-up. Out of the cases that continued pregnancy, with known follow-up, mortality was 68.75% in Group 1, 63.6% in Group
2, and 31.3% in Group 3 (the majority with severe ECAs). Surviving cases with DCM and myocarditis improved, 2 with HCM
worsened, 6 remained stable, and 26 improved or normalized. Conclusions. Our data show more severe prognosis in DCM and
myocarditis and forms with severe associated ECAs.
1.Introduction
Myocardial disease (MD) is a group of diseases with very
variable forms, etiology, entity, and natural history that are
mostly diagnosed in adolescence and adulthood [1]. It was
reported to occur in about 2–7% in the series of neonates
and infants [2, 3]. Fetal echocardiography allows now an
early recognition of MD, based upon the pattern of dilated
and hypocontractile ventricles or of a various degree and
localization of parietal hypertrophy. The frequency of MD in
fetal life is diﬃcult to establish—we can consider the ﬁgures
giveninsomefetalseries:inourexperienceitwasfoundin1–
1.7% of two series of pregnancies at risk for CHD studied by
fetal echocardiography, while its prevalence was 6.7%, 7.5%,
and 8.9% of cases with CHD [4–7].
Echocardiographic features and outcomes in utero of
cases with MD have been described in some studies [8–
10], however the data are very variable, being often included
also cases with some speciﬁc conditions like twin-to-twin
transfusionsyndromeorcasesassociatedwithanemia.Inthe
era of fetal echocardiography, the referral for familial MD is
quite frequent and the counseling in these cases is diﬃcult.
Therefore we feel it is of interest to have more data regarding
this pathology.
2. Objectivesof the Study
The aim of this paper is to analyse retrospectively our
experienceregardingthecharacteristicsandoutcomeofcases
with myocardial disease, detected at fetal echocardiography.
3.MaterialandMethods
Between 1990 and 2005, 91 fetuses (1.5%), out of around
6000 cases, referred for fetal echocardiography in 2 cen-
ters presented with a pattern of dilated or hypertrophic
cardiomyopathy (DCM, HCM), at 17–38 weeks’ gestation,
median 28. The fetuses were referred often for a ﬁnding of
abnormal cardiac features or of a fetal hydrops at obstetric2 International Journal of Pediatrics
scan: some came for a family history of HCM or for maternal
diabetes; and, also, the fetuses with extracardiac anomalies
were sent for an evaluation of the cardiac state. Cases
with twin-twin transfusion syndrome or anemia, as well as
those associated with speciﬁc congenital heart lesions were
excluded from this study. Infections, extracardiac anomalies
(ECAs) and maternal disease were always checked.
3.1. Methodology. Two-dimensional echocardiography with
M-mode and pulsed/continuous wave and Color Doppler
wereperformedusingtheechocardiographicmachines:Acu-
son Sequoia, Imagegate, Siemens, Erlangen, Germany, and
Vivid 7, General Electrics, Healthcare, Italy, with transducers
5 and 3.5MHz according to the fetal age.
Measurements of the right and left ventricles were done
in 2D in 4-chamber view in diastole (at the level of the mitral
and tricuspid valve anulus) and in M-mode in a horizontal
4-chambers view, measuring the thicknesses of the right
ventricular anterior wall, of the interventricular septum and
of the left ventricular posterior wall. Shortening fraction of
the left ventricle was calculated on the basis of the M-mode
measurements in systole and diastole (normal values 28–
42%).
Pulsed and Color Doppler examinations were always
performed,and,speciﬁcally,pulsedDopplerwaveformswere
analysed at the level of the atrioventricular and semilunar
valves and at the level of the inferior vena cava, ductus
venosus, and umbilical artery.
We used as a criterion for the diagnosis of DCM the
ventricular enlargement above the 97.5% according to the
normal standards for gestational age [11–13] without thick-
ening of the walls and with reduced contractility (shortening
fraction <28%).
The term of the “noncompaction” of the left ventricular
myocardium was used in cases that showed dilated ventricle
with reduced function and numerous prominent trabecu-
lations with deep myocardial recesses [14–16]. HCM was
diagnosed on the basis of an increased parietal thickness
above97.5%ofnormalstandardsforgestationalage[17,18].
In all cases, congenital heart anomaly was excluded.
Fetal hydrops was deﬁned by the presence of serous
eﬀusion in at least two compartments: of a mild degree,
when in 2 compartments (ascites+ hydropericardium or
hydrothorax),ofamoderatedegreewhenin3compartments
(ascites, hydrothorax, and hydropericardium), and severe,
with associated skull edema.
After the diagnosis was made, all cases were screened for
possible infections (parvovirus, Coxsackie, cytomegalovirus,
and toxoplasmosis), fetal anemia, and diabetes. The fetal
r h y t h mw a sa l w a y se v a l u a t e d .
3.2. Postnatal Assessment. In the cases born alive echocar-
diography was performed after birth, usually within the
ﬁrst day and repeated subsequently according to the clin-
ical necessity (median follow-up: 6years; range: 2–14).
Methodology of the examination was performed according
to the standard criteria, and M-mode measurements were
used for functional assessment, as exposed for the fetal
examination, comparing the data with normal standard
values for the infants’ weight and body surface area [19]. All
infants underwent a complete check-up of laboratory tests,
to exclude underlying conditions as metabolic disorders,
infections, and so forth.
3.3. Analysis of the Data. The characteristics of the cases
and their course in utero and after birth were analysed,
according to the type: Group 1-DCM, Group 2-documented
myocarditis, and Group 3-HCM.
3.4. Statistical Analysis. Gestational age at presentation in
cases that died and those who survived was compared by
means of Student’s test t for unpaired data, for single groups.
I n ﬂ u e n c eo fh y d r o p si nG r o u p s1a n d2a n do fe x t r a
cardiac anomalies in Group 3 on outcome was tested by
Student’s test t for paired data, and the diﬀerences in
outcomes in categories with and without hydrops in Groups
1 and 2 were compared by chi-square test.
4. Results
4.1. Features
Group 1 (see Table 1). Pattern of DCM with dilated left
v e n t r i c l ew a sf o u n di n1 8f e t u s e s ,a s s o c i a t e di n5( 1 5 . 8 % )
with extracardiac anomalies. One fetus had a form with
dilated right ventricle, associated with an abnormal tricuspid
valve apparatus.
Three fetuses presented a pattern of noncompacted
myocardium (2 siblings), and 8 fetuses had a highly
echodense endomyocardium, suggesting endocardial ﬁbroe-
lastosis (3 with ECA), with calciﬁcations in one case
(Figure 1(a)) that were documented also at postnatal X-ray
and at autopsy following the death in the 1st day of life. One
fetus had a family history of cardiomyopathy, in a 3-year-old
sibling aﬀected with a mild form.
Thirteen cases (68.4%) showed at presentation fetal
hydrops: 12 of a moderate-to-severe degree and 1 of a mild
degree.
Cardiac Function at Echocardiography. All cases had reduced
contractility—withfractionalshorteningrangingbetween10
and 20%, median 16. An abnormal pattern of systolic and
diastolic ﬂows of the mitral and tricuspid valves (reduced
E/A ratio and a small A-wave) and atrioventricular valves
regurgitation were seen at Echo-Doppler. All fetuses showed
mitral regurgitation of a mild-moderate degree, and the 13
cases with hydrops presented moderate-severe holosystolic
tricuspid regurgitation, associated with anomalous ﬂow of
the inferior vena cava and ductus venosus (a reverse A-wave
ﬂow in systole) and the ﬂuctuation of the umbilical venous
ﬂow in cases in preterminal condition.
Group 2 (see Table 1). T w e l v ef e t u s e sw i t hd o c u m e n t e dv i r a l
infection (5 with Cytomegalovirus and 7 with Coxsackie
virus) presented dilation of both ventricles (see Figure 1(b)),
with tricuspid and mitral regurgitation and fetal hydrops inInternational Journal of Pediatrics 3
Table 1: Data of cases with DCM and myocarditis.
Type of CMP N. W.g. at
dg.
Assoc.
ECAs Hydrops Arrh. Ther. in
utero
Outcome in
utero-w.g.
TP IUD
Delivery
Postnatal
death
Total death
of cases
continuing
pregn.
Alive/age
DCM LV
Idiopathic
Tot. 18
13
(1 Fam.,
3N C M ,
5E F E )
18–35,
(median
26)
9 1-SVT
1E x S
3-dig.
3–4d
1T P
2 IUD (24,
30w.g.)
2 lost, 8
delivered at
33–36w.g.
4 died 5a l i v ea t
3–10yrs,
improved
after 3
months–
1yr
With ECA 5 (3 EFE)
2r e n a l ,
1 CNS,
1 thor.cyst,
1 multiple
malform.
3
5 delivered
at 34–36
w.g.
4 died
DCM RV 1 32 1 Dig.
14d
Delivered
by CS at
34w.g.
Died
at day 1
DCM total 19 18–34 5 ECAs 13 (68.4%) 1 SVT 4 dig.
1T P ,
2IUD ,
2lost
9 died (4
ECAs)
11/16
(2 lost)
=68.75%
5/16 alive
(31.25%)
and
improved
Myocarditis 12
20–37
(median
23)
11 (91.7%)
(5 severe, 5
moder., 1
mild)
1T P ,
4I U Da t
23–30w.g.
7 delivered
at
28–40w.g.,
median 33
3 died
at day 1
7/11 =
63.6%
4a l i v e ,
improved
DCM LV, DCM RV: dilated cardiomyopathy of the left ventricle/right ventricle, n.: number, w.g.: weeks’ gestation, dg.: diagnosis, Fam.: familiarity, NCM:
noncompacted myocardium, ECAs: extracardiac anomalies, malform.: malformations, CNS: central nervous system, thor.: thoracic, arrh.: arrhythmias, SVT:
supraventriculartachycardia,ExS:supraventricularextrasystolia,ther.:therapy,dig.:digoxin,d:day,yr:years,TP:terminationofpregnancy,IUD:intrauterine
death, HF: hydrops fetalis, moder.: moderate, CS: caesarean section, and f-up: follow-up.
11 cases (91.7%), of a severe degree in 5 cases, of a moderate
degree in further 5 cases, and of a mild degree in one case.
All these case presented abnormal systolic left ventricular
or biventricular function and signs of regurgitation of both
atrioventricular valves, associated in the cases with fetal
hydrops to abnormal venous ﬂows, as described for Group
1 (see Figure 2).
Group 3 (see Table 2). Sixty fetuses presented HCM of the
left ventricle, with outﬂow tract obstruction in two; 10
also presented right ventricular hypertrophy; 26 (43.3%)
had extracardiac anomalies (ECAs), 3 cases were aﬀected
by syndromes precised after birth (1 Thomas syndrome, 1
Prune-Belly, and 1 Noonan).
Seventeen fetuses (28.3%) had mothers with diabetes
(pregestational in 12; gestational in 5); 17 fetuses were
considered to be “idiopathic”, however in one of them
a metabolic disorder (cytochrome-oxidase deﬁciency) was
foundpostnatally,while5remainingcasespresentedafamily
history of HCM.
Systolic function was normal or slightly increased (short-
ening fraction between 30 and 45%, median 36), some
fetuses showed signs of abnormal diastolic ﬂow through the
mitral valve (higher E-A velocities) at Echo-Doppler and
mild mitral regurgitation. The two cases with left ventricle
obstruction had slightly increased Doppler velocity through
the aorta (2 and 2.2m/sec.). Heart failure in utero was
infrequent and only mild (in 4/60 cases = 6.7%).
None of the fetuses with hypertrophy had features ﬁtting
for the diagnosis of restrictive cardiomyopathy—showing
no particular enlargement of atria and no speciﬁc Doppler
ﬁndings of mitral valve.
4.2. Outcome and Evolution: (See Tables 1 and 2 and Figure 3
with a Flow Chart)
4.2.1. DCM. Out of 19 cases with DCM, 1 opted for
termination of pregnancy (TP), 2 were lost at follow-up, and
total mortality was 11/16 cases that continued pregnancy and
with a known follow-up (68.75%). Eleven out of 13 cases
with fetal hydrops died (2 in utero). Two of the 3 cases with
noncompacted myocardium died in utero. Surviving cases
improved after 4 months–1 year.
4.2.2. Myocarditis. Out of 10 cases with moderate-to-severe
hydrops, 1 opted for TP and only 2 survived. One fetus with4 International Journal of Pediatrics
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Figure 1: (a) Echocardiography of a fetus with endocardial ﬁbroelastosis—a high echodensity of the left ventricular (LV) walls due to
calciﬁcations is evident. RV—right ventricle, A—aorta. (b) Fetus with myocarditis and fetal hydrops: both ventricles and atria are dilated
and the arrows indicate the pericardial eﬀusion. RV—right ventricle, LV—left ventricle.
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Figure 2: Doppler ﬁndings in fetuses with DCM and fetal hydrops: (a) The tracing of the tricuspid valve (T) shows a reduced systolic A-
wave, with respect to the diastolic E-wave; (b) holosystolic tricuspid regurgitation (ITr); (c) a reverse systolic ﬂow of the inferior vena cava
(small arrow); (d) a reverse systolic ﬂow of ductus venosus (small arrow); (e) the ﬂuctuation of the umbilical vein.
mild-initial hydrops that presented at 20w.g. and another
one who presented late at 37w.g. without hydrops survived.
Total mortality was 7/11 cases that continued pregnancy
(63.4%) Four cases that survived improved all after 3–12
months.
4.2.3. HCM
(a) Idiopathic Form. One out of 5 cases with familial
history (in mother, grandfather, or siblings) was diagnosed
after birth to have a metabolic disorder-cytochrome-oxidase
deﬁciency (as said above) and died at 38 days. The remaining
4 infants are alive at 5–14 years and present mild-moderate
forms, one needing recently, at 10 years, propranolol for a
moderate left ventricular obstruction.
Out of the 12 cases with a negative family history,1
case was lost at follow-up, 1 infant born premature for
fetal distress at 28w.g. died at 15 days and 2 other cases
worsened: one with a biventricular obstruction, shown inInternational Journal of Pediatrics 5
Table 2: Data of cases with HCM.
Type N. W.g. at
dg.
Assoc.
ECAs/ other
conditions
Heart
failure Arrh. Ther. in
utero
Outcome
in utero—
w.g.
TP IUD
Delivery
Postnatal
death
T o t a ld e a t ho f
cases
continuing
pregn.
Alive/age
“Idiop.” 17 5 familial
history —— —
1 lost
11
delivered
at
31-38w.g.
1–38d
(met.dis)
2/16 with
known f-up =
125%
14 alive at 2–14yrs:
3w o r s e n e d —1 Tx at 2m;
1o p e r a t e da t3y r s
for LVOT-mitral
tissue obstruction;
1 needing betablockers;
5 unchanged
(mild-moderate);
6i m p r o v e dat 3m–1yr.
12 no
familial
history
1p r e m .
born at 28
w.g. died
at 15 d.
Secondary to
ECA 26
17–30
Median
22
16 renal,
3 CNS,
7( s k e l e t a l
anom.,
arthrogry-
posis,
Thomas s.,
Noonan s.)
3( m i l d -
moder.)
8T P ,
6I U Da t
23–30w.g.,
12
delivered
at
28–37w.g.
7 (1–35d) 13/18 =
72.2% 5a l i v e ,regressed
Secondary to
maternal
diabetes
17 27–37 12 pregest.,
5g e s t . 1( m i l d ) 1ﬂ u t t e r D i g .∗
17
delivered
at
37–39w.g.
2( 2d ,
4m) 2/17 = 11.8% 15 alive, normalized at
3–6m
HCM total 60 17–39 4 (6.7%) 1 1
8T P ,
6I U D ,
1 lost,
45
delivered
11/51 with
known
f-up =
21.6%
17/51 with
known f-up =
33.3%
34 alive,
2 worsened,
6 unchanged,
26 improved/normalized
Idiop.: idiopathic, n.: number, w.g.: weeks’ gestation, dg.: diagnosis, ECAs: extracardiac anomalies, anom.: anomalies, CNS: central nervous system, s.:
syndrome, arrh.: arrhythmias, SVT: supraventricular tachycardia, ther.: therapy, dig.: digoxin, TP: termination of pregnancy, IUD: intrauterined e a t h ,d :d a y ,
m: month, yr: year, s.: syndrome, met.dis.: metabolic disease, prem.: premature, gest.: gestational, pregest.: pregestational, moder.: moderate, f-up: follow-up,
Tx: heart transplant, and LVOT: left ventricular outﬂow tract.
Figure 4, delivered at 32w.g., required a heart transplant at
2 months and is alive at 4 years, while the second one, also
with a biventricular obstruction since birth, treated with
betablockers, developed a severe left ventricular obstruction
due to an excessive mitral valve tissue at 3 years and needed a
cardiosurgical excision of this tissue together with a plasty of
the mitral valve. Two cases remained stable and 6 improved
at 3 months–1 year.
(b) HCM Secondary to ECA. Eight opted for TP, 6 had IUD
(5 renal anomalies-Potter syndrome and 1 Prune Belly).
Seven out of the 12 infants that are born alive died after birth
and 5 are alive at 5–12 years and improved.
One case with CNS anomaly was operated for cran-
iostenosis and is alive; equally, the infant with Noonan
syndrome suﬀered initially from pleural eﬀusions, stabilizing
thereafter.
(c) HCM Secondary to the Maternal Diabetes. One fetus of a
motherwithpregestationaldiabetespresentedat29w.g.with
mild fetalhydropsand atrialﬂutterresolved bythematernal-
fetal therapy, with digoxin was delivered at term showing
only a mild LV dyskinesis after birth, regressed at 1 month.
Two infants with pregestational maternal diabetes died:
one with a poor control of diabetes in pregnancy had a
severe HCM and died immediately after birth, of cardiac
arrest, while the second one, with a borderline thickness
of the interventricular septum in the third trimester and
immediately after birth, developed progressively a massive
parietal hypertrophy, obstruction of the left ventricular
outﬂow and died at 4 months of an untreatable heart failure.
All surviving cases with maternal diabetes progressively
normalized after 3–6 months.
Total mortality in HCM (Group 3) was 17/51 (33.3%)
of the cases continuing pregnancy with a known follow-up,6 International Journal of Pediatrics
91 fetuses
DCM-19 Myocarditis 12
1T P
2 IUD
2 lost
9N D
Mortality
68.75%
5 alive-
improved
1T P
4 IUD
3N D
Mortality
63.6%
4 alive-
improved
Idiop.
17
Secondary to
maternal diabetes
17
Secondary to
ECA
26
1 lost
2N D
Mortality
12.5%
14 alive:
3W ,5U ,
6i m p r o v e d
8T P
6 IUD
7N D
Mortality
72.2%
5 alive-
regressed
2N D
Mortality
11.8%
15 alive-
regressed
TP Termination pregnancy
IUD Intrauuterine death
ND Neonatal death
W Worsened
U Unchanged
Dilated form: 31 cases Hypertrophic form: 60 cases
Figure 3: Flow chart summarizing the frequency and the outcomes in the diﬀerent forms of myocardial disease.
13/18 (72.2%) of those with severeECA, and 2/17 (11.8%) of
infants with maternal diabetes.
4.3. Statistical Analysis. There were no signiﬁcant diﬀerences
between the age at presentation in cases with DCM and
myocarditis and relative outcome; cases with fetal hydrops
presented poor outcome, but the diﬀerences between cases
with and without hydrops did not reach statistical signiﬁca-
tivity.
In cases with HCM, a negative prognostic factor was
apparently the presence of a severe ECA, not reaching statis-
tical signiﬁcativity with respect to the remaining categories.
5. Discussion
Our data conﬁrm a variable spectrum of myocardial disease
presenting in the fetal age with diﬀerent etiology and the
possibility of association with extracardiac anomalies both
in hypertrophic and dilated forms. Hypertrophic form of
cardiomyopathy was more frequent in our series, both in
proportion versus the dilated form and with respect to the
twopreviousreports[7,10],and,particularly,wehavefound
arelevantnumberofcaseswithsecondaryforms.Ourﬁgures
may be partly due to the referral reasons, operating in the
third level centers for prenatal diagnosis where there is a
policy to perform the fetal echocardiography also in all cases
with extracardiac anomalies.
The dilated form of cardiomyopathy, either isolated
or associated to extracardiac anomalies or infections
(myocarditis) was related to a higher perinatal loss than the
hypertrophic form, considered on the whole. The outcomes
of cases with dilated form of cardiomyopathy was clearly
worse in presence of the fetal hydrops, despite the fact that
its presence, as well as the earlier age at presentation, did
notreachastatisticalsigniﬁcativity.Anequallyhighperinatal
lossof82%ofcaseswithDCMwasreportedbyotherauthors
[7].
Interestingly, 15.8% of our cases with DCM presented
also various extracardiac anomalies and some of these also
showed speciﬁc features of endocardial ﬁbroelastosis as well
as the fetuses with isolated, idiopathic form.
Family history of DCM was not frequent in our series;
it was present in only one of our cases, in a sibling, and
of a mild entity. On the other side, the familial DCM may
occur more frequently, with a possibility of recurrence in 20–
55% [20–22]. Often, there might be underlying metabolic
disorders, diﬃcult to precise in the fetal life, as it was in
the case of one of our infants; this fact shows how the term
of an “idiopathic” form may be incorrect, until a complete
evaluation after birth or later in life is done [22].
The problems of a variable timing of presentation of
DCM were shown in a fetal-postnatal study on cases with
a family history for a nonhypertrophic cardiomyopathy [23],
indicating a high recurrence rate of DCM (8/26 = 30.7%),
but only half of the cases presented already in utero, in theInternational Journal of Pediatrics 7
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Figure 4:(a)Fetuswithhypertrophiccardiomyopathyin2-D;(b)M-moderecordingshowinghypertrophyoftheleftventricularwalls,with
asmallcavityandmitralvalvemovementwithdiastolicappositionandanteriorsystolicmotion.RV—rightventricle,LV—leftventricle,M—
mitral valve.
third trimester (after normal ﬁndings at the mid-trimester),
while the remaining cases worsened after birth.
This fact makes it very diﬃcult or impossible to reassure
the women referred for the fetal echocardiography for the
family history, even in presence of normal fetal exams in the
third trimester.
5.1. Infections. The infective processes were often put in
relationship with the development of dilated cardiomyopa-
thy or endocardial ﬁbroelastosis, following to the ﬁnding
of antibodies anti-Coxsackie or other viruses in aﬀected
patients [7, 9]. Other agents, such as Cytomegalovirus,
Rubella virus, parvovirus, and adenovirus, may cause acute
myocarditis, with a high perinatal loss. Our cases were all
due to Cytomegalovirus and Coxsackie infection and the
outcome was poor in those with hydrops, while a few others
improved—one already during the fetal life.
A Recovery of the Left Ventricular Dysfunction. It, both
in cases of idiopathic DCM and after myocarditis, is known
to occur, with a variable frequency [24, 25]. Eﬀectively,
around one third of our surviving cases with DCM and with
myocarditis improved at follow-up, after 3 months–1 year.
5.2. Association with Arrhythmias. Tachy- or bradyarrhyth-
mias induce potentially the left ventricular impairment, but
there may probably be cases with a major predisposition
for the left ventricular impairment in some cases. In our
experience (of more than 50 tachyarrhythmias) we have
found only one fetus presenting with a speciﬁc pattern of
DCM. Also the fetuses carrying antibodies anti-Ro, anti-La,
passed through placenta from mothers aﬀected with clinical
latent immunological disease, may have a predisposition for
the development of DCM [26, 27].
Noncompactionof theLeftVentricle. It is a particular form
of myocardial disease due to a failure of a normal embry-
ological process of myocardial compaction and the cases
aﬀected present a variable degree of functional impairment
and therefore a variable outcome [14–16]. This condition
may be familial, as it occurred in two of our cases—siblings.
Hypertrophic Form of Cardiomyopathy. It was more
frequent in our series than the dilated form, as mentioned
above. HCM is known to be transmitted in some families by
autosomal dominant type, with a variable severity. Some of
our familial index cases presented a rather mild form of the
disease, which increases the diﬃculty of predicting a possible
recurrence later in infancy or in adulthood.
In the fetal life it is diﬃcult to exclude an underlying
metabolic disease as glycogenosis or other inborn errors
of metabolism found after birth as in one of our cases.
Therefore it is imperative to perform a detailed postnatal
checkup for metabolic of infective conditions.
Wehavefoundduringtheperiodofthisstudyalsoalarge
number of cases with secondary forms of HCM, in presence
of some extracardiac anomalies or of the maternal diabetes.
Hypertrophy secondary to renal anomalies was described
also in another experience [28], and it probably has a similar
pathophysiological explanation in the action of angiotensin-
reninsystem,aspostnatally.Otherextracardiacanomalies,as
those of CNS, or multiple anomalies, do not have apparently
a clear etiopathogenesis.
Also syndromes as Noonan’s can present as HCM,
without other associated intracardiac lesions, and in our
series we also had a fetus with another rare condition—
Thomas’s syndrome, deﬁned only after birth.
A more common form of a secondary HCM is the
one related to the maternal pregestational diabetes [29], in
which there is an accumulation of glycogen, due to a poorly
c o n t r o l l e dg l u c o s em e t a b o l i s m .T h e s ef o r m sa r ee x p e c t e d
nowadaystobelessfrequent,withabettercontrolofmothers
aﬀected. Our series includes, however, 2 earlier cases who
died after birth with features of a marked HCM. Otherwise,
these fetuses present usually only minor anomalies of the
diastolic ﬂow through the mitral valve due to an impaired8 International Journal of Pediatrics
compliance [30], but have generally a progressive regression
of hypertrophy and normalization after birth, as occurred in
all surviving infants of our series.
The evolutivity of HCM is variable, at times worsening,
as occurred in two of our cases, one of which needed a heart
transplant very early, at 2 months; otherwise some cases can
improve or completely regress, mainly the secondary forms,
when not related to severe extracardiac anomalies. Echocar-
diographic follow-up allows nowadays a better assessment of
the natural history of aﬀected cases.
6. Conclusions
Our data conﬁrm a variable spectrum of myocardial disease
in the fetal age, with a possible association of extracardiac
anomalies in both forms and more severe prognosis in
DCM and myocarditis and in HCM associated with severe
extracardiac anomalies. We have to underline the delicacy of
the prenatal counseling, in cases with familial history, due
to an impossibility to exclude a further presentation of the
disease later in infancy or adulthood, as well as a potential
associationwithmetabolicorsyndromicdisordersdetectable
only after birth.
As a policy, it is imperative to perform a complete
evaluationoftheextracardiacorgansinuteroandathorough
postnatal check-up aiming to exclude underlying conditions.
The limits of the early detection of myocardial disease are
obviouslygreaterinfetusesexaminedinthesecondtrimester,
therefore it is recommendable to repeat the examination in
the third trimester and after birth. The cases with family
history should also be followed up echocardiographically
even later, during infancy and adolescence.
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